Differential modulation of expression of the two acylphosphatase isoenzymes by thyroid hormone.
The modulation of expression of the skeletal muscle and erythrocyte acylphosphatase isoenzymes by thyroid hormone has been investigated. Our results indicate a differential regulation of the two enzymic isoforms by tri-iodothyronine (T3) in K562 cells in culture: an increase in the specific mRNA during T3-stimulation is shown only for the skeletal muscle isoenzyme. A fast and transient T3 induction of the accumulation of the specific mRNA can be observed, reaching a maximum 8 h after hormone treatment and then rapidly decreasing almost to the steady-state level after 24 h. A nuclear run-on assay was performed to explore the mechanisms of this regulation. These studies indicate that T3 induction of skeletal muscle acylphosphatase mRNA is due, at least in part, to a fast and transient increase in the rate of gene transcription, within 4 h after hormone administration. A very rapid decrease is then observed within a further 2 h. T3-dependent accumulation of the mRNA for the skeletal muscle acylphosphatase requires ongoing protein synthesis, as confirmed by inhibition with cycloheximide or puromycin. These findings indicate that the transcriptional regulation of the gene may be indirect.
D017766:Acid Anhydride Hydrolases / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D000595:Amino Acid Sequence; D001483:Base Sequence; D015152:Blotting, Northern; D002478:Cells, Cultured; D015342:DNA Probes; D018076:DNA, Complementary / Q000737:chemistry; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis* / Q000235:genetics; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000187:drug effects / Q000201:enzymology*; D009838:Oligodeoxyribonucleotides / Q000737:chemistry; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D016415:Sequence Alignment; D014284:Triiodothyronine / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D000097024:Acylphosphatase
D017766:Acid Anhydride Hydrolases; D015342:DNA Probes; D018076:DNA, Complementary; D007527:Isoenzymes; D009838:Oligodeoxyribonucleotides; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D014284:Triiodothyronine; D000097024:Acylphosphatase